Actively Recruiting
Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Led by Chinese University of Hong Kong · Updated on 2024-08-21
700
Participants Needed
1
Research Sites
299 weeks
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
T
The University of Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
(a) Objectives 1. To assess the full lung function, exercise capacity, quality of life in patients with COVID-19 over 2 years. 2. To assess the longevity of the serology response to SARS-CoV2. 3. To investigate the association of the neutralization titer in plasma from different vaccinated cohorts to its protection of infection using in vivo model 4. To investigate the SARS-CoV-2 specific cellular and humoral immunities as well as their determinant factors from community subjects who have received different types of COVID-19 vaccines. 5. To assess the third booster dose for subjects who have poor antibody response despite having received two doses of CoronaVac (Sinovac)
CONDITIONS
Official Title
Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have been discharged from hospital following treatment for COVID-19
You will not qualify if you...
- Unwilling to be follow up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
S
Susanna Ng, MBChB
CONTACT
K
Karen Yiu, BSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here